NUB1 modulation of GSK3β reduces tau aggregation

Human Molecular Genetics

Volumn 21, Issue 24, 2012, Pages 5254-5267

  Richet, Emma ^a   Pooler, Amy M ^b   Rodriguez, Teresa ^b   Novoselov, Sergey S ^a   Schmidtke, Gunter ^c   Groettrup, Marcus ^c   Hanger, Diane P ^b   Cheetham, Michael E ^a   van der Spuy, Jacqueline ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; NEDD8 ULTIMATE BUSTER 1; PROTEASOME; TAU PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL INCLUSION; CONTROLLED STUDY; ENZYME DEGRADATION; GENE SILENCING; HUMAN; HUMAN CELL; NERVE DEGENERATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELLS, CULTURED; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GLYCOGEN SYNTHASE KINASE 3; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; PHOSPHORYLATION; PROTEIN BINDING; RATS; RNA INTERFERENCE; TAU PROTEINS;

EID: 84870320500     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/dds376     Document Type: Article

References (46)

1. Dehmelt, L. and Halpain, S. (2005) The MAP2/Tau family of microtubule-associated proteins. Genome. Biol., 6, 204.
2. Morris, M., Maeda, S., Vossel, K. and Mucke, L. (2011) The many faces of tau. Neuron., 70, 410-426.
3. Buee, L., Bussiere, T., Buee-Scherrer, V., Delacourte, A. and Hof, P.R. (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res. Brain Res. Rev., 33, 95-130.
4. Martin, L., Latypova, X. and Terro, F. (2011) Post-translational modifications of tau protein: implications for Alzheimer's disease. Neurochem. Int., 58, 458-471.
5. Yancopoulou, D. and Spillantini, M.G. (2003) Tau protein in familial and sporadic diseases. Neuromolecular Med., 4, 37-48.
6. Lee, V.M., Goedert, M. and Trojanowski, J.Q. (2001) Neurodegenerative tauopathies. Annu. Rev. Neurosci., 24, 1121-1159.
7. Hanger, D.P., Anderton, B.H. and Noble, W. (2009) Tau phosphorylation: the therapeutic challenge for neurodegenerative disease. Trends Mol. Med., 15, 112-119.
8. Hooper, C., Killick, R. and Lovestone, S. (2008) The GSK3 hypothesis of Alzheimer's disease. J. Neurochem., 104, 1433-1439.
9. Hernandez, F., Gomez de, B.E., Fuster-Matanzo, A., Lucas, J.J. and Avila, J. (2010) GSK3: a possible link between beta amyloid peptide and tau protein. Exp. Neurol., 223, 322-325.
10. Lei, P., Ayton, S., Bush, A.I. and Adlard, P.A. (2011) GSK-3 in Neurodegenerative Diseases. Int. J. Alzheimers Dis., 189246, 9.
11. Townsend, M., Mehta, T. and Selkoe, D.J. (2007) Soluble Abeta inhibits specific signal transduction cascades common to the insulin receptor pathway. J. Biol. Chem., 282, 33305-33312.
12. Magdesian, M.H., Carvalho, M.M., Mendes, F.A., Saraiva, L.M., Juliano, M.A., Juliano, L., Garcia-Abreu, J. and Ferreira, S.T. (2008) Amyloid-beta binds to the extracellular cysteine-rich domain of Frizzled and inhibits Wnt/beta-catenin signaling. J. Biol. Chem., 283, 9359-9368.
13. Takashima, A., Noguchi, K., Michel, G., Mercken, M., Hoshi, M., Ishiguro, K. and Imahori, K. (1996) Exposure of rat hippocampal neurons to amyloid beta peptide (25-35) induces the inactivation of phosphatidyl inositol-3 kinase and the activation of tau protein kinase I/glycogen synthase kinase-3 beta. Neurosci. Lett., 203, 33-36.
14. Peineau, S., Bradley, C., Taghibiglou, C., Doherty, A., Bortolotto, Z.A., Wang, Y.T. and Collingridge, G.L. (2008) The role of GSK-3 in synaptic plasticity. Br. J. Pharmacol., 153, S428-S437.
15. Eldar-Finkelman, H. and Martinez, A. (2011) GSK-3 inhibitors: preclinical and clinical focus on CNS. Front Mol. Neurosci., 4, 32.
16. Lucas, J.J., Hernandez, F., Gomez-Ramos, P., Moran, M.A., Hen, R. and Avila, J. (2001) Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice. EMBO J., 20, 27-39.
17. Johnson, G.V. and Stoothoff, W.H. (2004) Tau phosphorylation in neuronal cell function and dysfunction. J. Cell Sci., 117, 5721-5729.
18. Rankin, C.A., Sun, Q. and Gamblin, T.C. (2008) Pre-assembled tau filaments phosphorylated by GSK-3b form large tangle-like structures. Neurobiol. Dis., 31, 368-377.
19. Goldbaum, O., Oppermann, M., Handschuh, M., Dabir, D., Zhang, B., Forman, M.S., Trojanowski, J.Q., Lee, V.M. and Richter-Landsberg, C. (2003) Proteasome inhibition stabilizes tau inclusions in oligodendroglial cells that occur after treatment with okadaic acid. J. Neurosci., 23, 8872-8880.
20. Caccamo, A., Oddo, S., Tran, L.X. and LaFerla, F.M. (2007) Lithium reduces tau phosphorylation but not A beta or working memory deficits in a transgenic model with both plaques and tangles. Am. J. Pathol., 170, 1669-1675.
21. Oddo, S. (2008) The ubiquitin-proteasome system in Alzheimer's disease. J. Cell Mol. Med., 12, 363-373.
22. Dil Kuazi, A., Kito, K., Abe, Y., Shin, R.W., Kamitani, T. and Ueda, N. (2003) NEDD8 protein is involved in ubiquitinated inclusion bodies. J. Pathol., 199, 259-266.
23. Merlet, J., Burger, J., Gomes, J.E. and Pintard, L. (2009) Regulation of cullin-RING E3 ubiquitin-ligases by neddylation and dimerization. Cell. Mol. Life Sci., 66, 1924-1938.
24. Kamitani, T., Kito, K., Fukuda-Kamitani, T. and Yeh, E.T. (2001) Targeting of NEDD8 and its conjugates for proteasomal degradation by NUB1. J. Biol. Chem., 276, 46655-46660.
25. Hartmann-Petersen, R. and Gordon, C. (2004) Integral UBL domain proteins: a family of proteasome interacting proteins. Semin. Cell Dev. Biol., 15, 247-259.
26. Rani, N., Aichem, A., Schmidtke, G., Kreft, S.G. and Groettrup, M. (2012) FAT10 and NUB1L bind to the VWA domain of Rpn10 and Rpn1 to enable proteasome-mediated proteolysis. Nat. Commun., 3, 749.
27. Tanaka, T., Kawashima, H., Yeh, E.T. and Kamitani, T. (2003) Regulation of the NEDD8 conjugation system by a splicing variant, NUB1L. J. Biol. Chem., 278, 32905-32913.
28. Schmidtke, G., Kalveram, B., Weber, E., Bochtler, P., Lukasiak, S., Hipp, M.S. and Groettrup, M. (2006) The UBA domains of NUB1L are required for binding but not for accelerated degradation of the ubiquitin-like modifier FAT10. J. Biol. Chem., 281, 20045-20054.
29. Bett, J.S., Kanuga, N., Richet, E., Schmidtke, G., Groettrup, M., Cheetham, M.E. and van der Spuy, J. (2012) The inherited blindness protein AIPL1 regulates the ubiquitin-like FAT10 pathway. PLoS One., 7, e30866.
30. Tanji, K., Tanaka, T., Mori, F., Kito, K., Takahashi, H., Wakabayashi, K. and Kamitani, T. (2006) NUB1 suppresses the formation of Lewy body-like inclusions by proteasomal degradation of synphilin-1. Am. J. Pathol., 169, 553-565.
31. Tanji, K., Mori, F., Kito, K., Kakita, A., Mimura, J., Itoh, K., Takahashi, H., Kamitani, T. and Wakabayashi, K.J. (2011) Synphilin-1-binding protein NUB1 is colocalized with nonfibrillar, proteinase K-resistant a-synuclein in presynapses in Lewy body disease. J Neuropathol. Exp. Neurol., 70, 879-889.
32. Liu, G. and Xirodimas, D.P. (2010) NUB1 promotes cytoplasmic localization of p53 through cooperation of the NEDD8 and ubiquitin pathways. Oncogene, 29, 2252-2261.
33. Utton, M.A., Noble, W.J., Hill, J.E., Anderton, B.H. and Hanger, D.P. (2005) Molecular motors implicated in the axonal transport of tau and alpha-synuclein. J. Cell Sci., 118, 4645-4654.
34. Chun, W., Waldo, G.S. and Johnson, G.V.W. (2007) Split GFP complementation assay: a novel approach to quantitatively measure aggregation of tau in situ: effects of GSK3b activation and caspase 3 cleavage. J. Neurochem., 103, 2529-2539.
35. Bolte, S. and Cordelieres, F.P. (2006) A guided tour into subcellular colocalization analysis in light microscopy. J. Microsc., 224, 213-232.
36. Bruijn, L.I., Krishnamurthy, P.K. and Gallo, J.M. (2004) Distinct patterns of tau-dependent process formation in mammalian cell lines. Neuroreport, 15, 2223-2226.
37. Braak, H. and Braak, E. (1995) Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol. Aging, 16, 271-278.
38. Zhang, Z-W., Kang, J.I. and Vaucher, E. (2011) Axonal varicosity density as an index of local neuronal interactions. PLoS ONE., 6, e22543.
39. Callahan, L.M. and Coleman, P.D. (1995) Neurons bearing neurofibrillary tangles are responsible for selected synaptic deficits in Alzheimer's disease. Neurobiol. Aging, 16, 311-314.
40. Sokolow, S., Henkins, K.M., Williams, I.A., Vinters, H.V., Schmid, I., Cole, G.M. and Gylys, K.H. (2011) Isolation of synaptic terminals from Alzheimer's disease cortex. Cytometry A, 81, 248-54.
41. Kalveram, B., Schmidtke, G. and Groettrup, M. (2008) The ubiquitin-like modifier FAT10 interacts with HDAC6 and localizes to aggresomes under proteasome inhibition. J. Cell Sci., 121, 4079-4088.
42. van der Spuy, J. and Cheetham, M.E. (2004) The Leber congenital amaurosis protein AIPL1 modulates the nuclear translocation of NUB1 and suppresses inclusion formation by NUB1 fragments. J. Biol. Chem., 279, 48038-48047.
43. Lovestone, S., Reynolds, C.H., Latimer, D., Davis, D.R., Anderton, B.H., Gallo, J.M., Hanger, D., Mulot, S., Marquardt, B. and Stabel, S. (1994) Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells. Curr. Biol., 4, 1077-1086.
44. Pooler, A.M., Usardi, A., Evans, C.J., Philpott, K.L., Noble, W. and Hanger, D.P. (2012) Dynamic association of tau with neuronal membranes is regulated by phosphorylation. Neurobiol. Aging, 33, 431-438.
45. Zhang, X., Zhang, Y., Liu, S., Bulloj, A., Tong, G.G., Zhang, Z., Liao, F-F. and Xu, H. (2006) Tumor suppressor PTEN affects tau phosphorylation: deficiency in the phosphatase activity of PTEN increases aggregation of an FTDP-17 mutant tau. Mol. Neurodegen., 1, 7.
46. Evans, R.J., Schwarz, N., Nagel-Wolfrum, K., Wolfrum, U., Hardcastle, A.J. and Cheetham, M.E. (2010) The retinitis pigmentosa protein RP2 links pericentriolar vesicle transport between the Golgi and the primary cilium. Hum. Mol. Genet., 19, 1358-1367